Detection of benzodiazepines in the unregulated drug supply using point of care and confirmatory drug checking technologies: A validation study
FTIR did not consistently detect the presence of benzodiazepines and related compounds at point-of-care. However, sensitivity improved when FTIR was combined with immunoassay strips, underscoring the importance of using both technologies in tandem. As etizolam is not a true benzodiazepine, it poses considerable challenges using existing point-of-care drug checking technologies.
Authors
- Lianping Ti (ORCID: https://orcid.org/0000-0003-2470-438X)
- Samuel Tobias (ORCID: https://orcid.org/0000-0001-6051-8950)
- Evan Wood (ORCID: https://orcid.org/0000-0001-9412-6699)
- Hannah Crepeault (ORCID: https://orcid.org/0000-0003-1675-5144)
- Mark Lysyshyn (ORCID: https://orcid.org/0000-0001-6684-2030)
- Stephanie Dubland
- Jennifer Angelucci
Institutions
- Vancouver Coastal Health (CA)
- British Columbia Institute of Technology (CA)
- British Columbia Centre on Substance Use (CA)
Publication Details
- Journal
- Drug and Alcohol Dependence
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1016/j.drugalcdep.2025.112631
- Citations
- 3
- Primary Topic
- Forensic Toxicology and Drug Analysis
- Type
- article
- Field-Weighted Citation Impact
- 3.92